About Us  |  BVA-100  |  Investor Relations  |  IDANT Division  |  Contact Us
 

About Us: Contact Us

 
 

2/28/2014 - Daxor Corporation Announces Filing of Form N-CSR for December 31, 2013

  

2/11/2014 - Daxor Corporation Announces Dr. Joseph Feldschuh, President and CEO, Sustained a Fractured Hip, Had Emergency Surgery, and Received a Transfusion of His Own Frozen Blood Which Had Been Stored Four Years Ago

  

1/15/2014 - Daxor Announces a Research Study That Proves Micro Samples are Feasible for Accurate Blood Volume Measurements on Infants and Small Children Utilizing the BVA-100 Blood Volume Analyzer

  
 

______________________

 
     
  Form N-CSR for Dec 31, 2013  
  Form N-Q for Sep 30, 2013  
  Form N-CSR for June 30, 2013  
  Form N-Q for Mar 31, 2013  
 
Corporate Headquarters DAXOR Corporation
Empire State Building
350 Fifth Ave., Suite 7120
New York, NY 10118
Phone: 212-330-8500
Fax: 212-244-0806
E-mail: info@daxor.com
Customer Support Office: 888-774-3268
8:00 a.m. to 5:00 p.m., M-F
Technical Support Office: 865-425-0555
E-mail: support@daxor.com
By Department  

Accounting

David Frankel
Office: 212-330-8504
E-mail: dfrankel@daxor.com

Human Resources

Diane Meegan
Office: 212-330-8512
E-mail: dmeegan@daxor.com

Investor Relations

Diane Meegan
Office: 212-330-8512
E-mail: dmeegan@daxor.com

Quality Assurance

Office: 865-425-0555
E-mail: support@daxor.com

Clinical  Support

Dr. Joseph Feldschuh, M.D.
Chief Scientific Officer
Office: 212-330-8500
E-mail: jfeldschuh@daxor.com

Sales

To request information or to have someone get in touch with you, please contact Richard Dunn.
Office: 212-330-8502
E-mail: rdunn@daxor.com
Menu Options

DAXOR Home Page

Mission Statement

Privacy Statement

Company Management

Careers

Contact Us

 

 

Corporate
Headquarters

350 Fifth Ave.
Suite 7120
New York, NY 10118
Phone: 212-330-8500
Fax: 212-244-0806


© 2014 DAXOR Corporation. All Rights Reserved.